A Look at UroGen Pharma's Upcoming Earnings Report

UroGen Pharma URGN is preparing to release its quarterly earnings on Monday, 2025-05-12. Here’s a brief overview of what investors should keep in mind before the announcement.

Analysts expect UroGen Pharma to report an earnings per share (EPS) of $-0.80.

UroGen Pharma bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Earnings Track Record

In the previous earnings release, the company missed EPS by $0.08, leading to a 9.07% increase in the share price the following trading session.

Here’s a look at UroGen Pharma’s past performance and the resulting price change:

Performance of UroGen Pharma Shares

Shares of UroGen Pharma were trading at $10.67 as of May 08. Over the last 52-week period, shares are down 19.43%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for UroGen Pharma visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.